How long does immunotherapy work for mesothelioma?



The duration of effectiveness of immunotherapy for mesothelioma can vary greatly among individuals. While some patients may experience benefits lasting for years, others may not respond as effectively or for as long. Clinical trials like CheckMate 743 have shown promising results, with some patients seeing their tumors held at bay for up to two years with a combination of Opdivo and Yervoy.

However, it’s crucial to recognize that our understanding of immunotherapy’s benefits for mesothelioma is still evolving. As such, it’s essential for interested patients to engage in discussions with mesothelioma specialists. These specialists can provide insights into study data, share their professional experiences, and help patients make informed decisions about their treatment options. Each patient’s case is unique, and a tailored approach guided by expert medical advice is key.